May 05, 2026
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.
On April 20, 2026, and April 22, 2026, Huons Co. Ltd. initiated voluntary recalls of lidocaine HCl Injection, USP, and bupivacaine HCl in dextrose Injection for all lots. The recall was prompted by quality issues identified during a recent FDA manufacturing facility inspection, with a potential health hazard, including a small number of reports of drug ineffectiveness. Lidocaine HCl injection is FDA approved to produce local or regional anesthesia, and bupivacaine HCl in dextrose injection is FDA approved for spinal anesthesia. To read about the recall, see here and here.
Last updated: May 05, 2026